Study Confirms High Survival Rates for Men with Low-Risk Prostate Cancer

700+ women gather in Illinois to fund prostate cancer research

DEER CREEK, Ill. (WMBD) -- Drinks were raised Friday afternoon to toast to the advancements made in prostate cancer research at the annual all-female Fun Friday Float event. "We're in our 11th annual Female Friday Fun Float for prostate cancer. Our charity is the Prostate Cancer Foundation of Chicago. Last year we had 660 girls and this year we have 700," said Kim Williams, organizer of the event. The event is to raise money for prostate cancer …

Study confirms high survival rates for men with low-risk prostate cancer

New research in the July 2025 issue of JNCCN-Journal of the National Comprehensive Cancer Network finds that for people diagnosed with nonmetastatic low-risk prostate cancer later in life, and treated according to NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), 90% were likely to survive their cancer for their remaining life-expectancy.

Prostate cancer is unlikely to kill men if it's low risk and treated according to best practices, study finds

People with low-risk prostate cancer treated according National Comprehensive Cancer Network guidelines are more likely to die of other causes, new research shows.

Rethinking Masculinity in Men’s Health

Too many men ignore symptoms until they can no longer function. We end up seeing them in the emergency room, sometimes with late-stage cancer or uncontrolled chronic disease that could have been managed if addressed earlier. The post Rethinking Masculinity in Men’s Health appeared first on MedCity News.

New Research in JNCCN Offers Reassurance About Localized Prostate Cancer Prognosis

A study out of Sweden finds that people diagnosed with localized prostate cancer are unlikely to die from the cancer if they are treated according to NCCN Guidelines.